Dr. Christopher Ryan Keller, MD

Dr. Keller practices at Caldwell Dialysis Center in Utica, Michigan.

Dr. Keller's NPI, 1255467312, was assigned on February 25, 2007. Dr. Keller graduated from UCSF School of Medicine in 2003. Dr. Keller holds Idaho license M10236.

Dr. Keller's primary practice is Caldwell Dialysis Center, at 45640 Schoenherr Rd, Utica, MI 48315 in Macomb County. The practice phone is (208) 454-8260.

Dr. Keller's primary practice is Caldwell Dialysis Center in Utica, Michigan. Dr. Keller is also affiliated with St. Luke's Boise Medical Center. The medical group on file is St. Luke's Health System. Dmand AI also links Dr. Keller to 4 more hospitals and 3 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keller practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Keller's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Keller is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Keller's licenses on file in 3 states: Idaho, Oregon and California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and parathyroid gland disorder among the conditions Dr. Keller treats.

CMS data shows 1,135 Medicare services from Dr. Keller across 12 procedure codes in 2024, for 347 Medicare patients. Medicare paid $110,170 for them.

CMS counts 347 Medicare patients who saw Dr. Keller in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keller's median patient age at 71, with 52% women.

In 2024, Dr. Keller wrote 6,755 Medicare Part D claims for 679 patients. 80% of them were for generic drugs. CMS names the drug for 6,235 of them, across 92 drugs with 11 or more claims each, at $1,538,537 in total drug cost. In 2023, CMS named 5,686 claims across 89 drugs.

Dr. Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Keller as offering telehealth.

Dmand AI links 2 papers to Dr. Keller, published from 2008 to 2009. The most frequent topics are C-Reactive Protein, Cystatin C and Glomerular Filtration Rate. Dr. Keller's most frequent co-author is Michael George Shlipak, MD.

Dmand AI links Dr. Keller to 1 clinical trial. Conditions studied include Renal Insufficiency, Chronic and Renal Insufficiency. Open Payments lists research payments to Dr. Keller that name 1 trial.

CMS Open Payments shows 57 general payments to Dr. Keller from 21 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 66% of the total. Fresenius USA Inc. paid the most, $375. It also lists 1 research payment totaling $150 in 2016, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Keller, most recently CMS Stage 1 EHR in 2013.

Dr. Keller graduated from UCSF School of Medicine in 2003. Dr. Keller is a member of ACP.

Dr. Keller is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.